Research Library

Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor, write experts Kenneth M. Evans, Kirstin R.W. Matthews and Daniel Moralí. Baker Institute blog: http://bit.ly/2MDRDbW

While the U.S. still maintains the overall lead in Nobel prizes (with the exception of literature), the rate at which American scientists have been awarded the prize has declined since the late 1970s. Fellow Kirstin R.W. Matthews and postdoctoral fellow Kenneth M. Evans explore the state of scientific collaboration in the U.S. in this Baker Institute blog: https://bit.ly/2yiNhzF

Fellow Joe Barnes looks back, and ahead, at the impact of President Obama's foreign policies.

This paper critiques the Mexican government's efforts to train the country's workers for jobs created by energy reforms.

Five years after the Jasmine Revolution, Tunisia stands alone as the only country in North Africa where the Arab Spring has led to significant reforms and a democratic transition. Reservations have been voiced, however, on the gender equality provisions in the country’s revised constitution.

Latin America Initiative director Erika de la Garza blogs on the murder of Honduras activist Berta Cáceres, who was in Houston last November to receive an award for her work on behalf of Honduras’ indigenous communities.

On Feb. 24, 2015, public finance fellow John Diamond testified on tax reform before U.S. Senate Finance Committee.

Neal Lane, senior fellow in science and technology policy, testified before the Senate Committee on Commerce, Science and Transportation on July 17, 2014. Lane is co-chair of the American Academy of Arts and Science's project on New Models for U.S. Science and Technology Policy, and his testimony addressed the project's objective of sustaining a long-term, nonpartisan, national focus on science and technology policy issues of vital importance to the country.

A rise in the average age of biomedical researchers might inhibit research potential and novel projects that could impact biomedicine and the next generation of scientists in the United States.